Aptamer Based Quartz Crystal Microbalance
Biosensor Market size was valued at US$ 45.8 million in 2024 and is projected to reach US$ 87.9 million by 2032, at a CAGR of 8.5% during the forecast period 2025-2032
Report Studies
• The global Aptamer Based Quartz Crystal Microbalance Biosensor Market size was valued at US$ 45.8 million in 2024 and is projected to reach US$ 87.9 million by 2032, at a CAGR of 8.5% during the forecast period 2025-2032. The U.S. market accounted for approximately 35% of global revenue in 2024, while China is expected to witness the fastest growth with a projected CAGR of 9.2% through 2032.
• Aptamer-based QCM biosensors are high-precision analytical devices that utilize synthetic oligonucleotides (aptamers) as biorecognition elements on quartz crystal surfaces. These sensors detect mass changes at the nanogram level when target molecules bind to immobilized aptamers, enabling real-time, label-free analysis of biomolecular interactions. Key applications include drug discovery, environmental monitoring, and clinical diagnostics.
By Type:
• The market is segmented based on type into:
• Metal Biosensors
• Subtypes: Gold-coated, silver-coated and others
• Oxide Biosensors
• Carbide Biosensors
• Polymer Biosensors
• Subtypes: Conducting polymers, biocompatible polymers and others
• Others
• The market is segmented based on application into:
• Universities
• Life Science Companies
• Biotechnology Research Centers
• Pharmaceutical Laboratories
• Others
Key Players:
• Biolin Scientific (Sweden)
• 3T Analytik GmbH (Germany)
• NXP Semiconductors (Netherlands)
• Analog Devices, Inc. (U.S.)
• AWSensors (Spain)
• MicroVacuum Ltd. (Hungary)A
